Kristina Schilling
Overview
Explore the profile of Kristina Schilling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfrepper C, Siecke A, Klamroth R, Kuhnol C, Kentouche K, Holzhauer S, et al.
Hamostaseologie
. 2025 Feb;
PMID: 39965757
Introduction: Treatment options for patients with hemophilia (PWH) have changed substantially in the last years. This study aimed to compare hemophilia treatment in the eastern part of Germany in 2021...
2.
Tekbas A, Schilling K, Fahrner R, Morath O, Malessa C, Bauschke A, et al.
Transplant Proc
. 2024 Sep;
56(8):1759-1765.
PMID: 39237386
Myeloproliferative neoplasms can cause primary Budd-Chiari-Syndrome with acute or chronic liver failure necessitating liver transplantation. However, preventing the recurrence remains challenging and the need for post-transplant anticoagulant and cytoreductive treatment...
3.
Morath O, Hoffmann J, Schilling K, Hochhaus A, Rachow T, Lang S
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999338
: Patients with lung cancer face an increased incidence of venous (VTE) and arterial (ATE) thromboembolism. Risk factors for thrombosis remain unclear, particularly the impact of the use of immune...
4.
Pfrepper C, Klamroth R, Oldenburg J, Holstein K, Eichler H, Hart C, et al.
Hamostaseologie
. 2023 Dec;
44(6):466-471.
PMID: 38049124
Background: Acquired hemophilia A (AHA) is a severe bleeding disorder caused by autoantibodies against coagulation factor VIII (FVIII). Standard treatment consists of bleeding control with bypassing agents and immunosuppressive therapy....
5.
Mahn R, Schilling K, Klamroth R, Kentouche K, Aumann V, Fischer L, et al.
Hamostaseologie
. 2019 Nov;
40(1):119-127.
PMID: 31711245
Introduction: In 2005 the Kompetenznetz Hämorrhagische Diathese Ost published epidemiologic data about patients with haemophilia A (HA) and haemophilia B (HB) in the eastern part of Germany. This study provides...
6.
Brioli A, Klaus M, Sayer H, Scholl S, Ernst T, Hilgendorf I, et al.
Ann Hematol
. 2019 Jan;
98(3):713-722.
PMID: 30680505
Infections represent a major cause of morbidity and mortality in multiple myeloma and are linked to both therapy- and disease-related factors. Although it has been suggested that the rate of...
7.
Appelmann I, Kreher S, Parmentier S, Wolf H, Bisping G, Kirschner M, et al.
Ann Hematol
. 2016 Feb;
95(5):707-18.
PMID: 26916570
Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPN) comprise a heterogeneous group of chronic hematologic malignancies. The quality of life, morbidity, and mortality of patients with MPN are primarily affected by disease-related symptoms,...
8.
Tiede A, Klamroth R, Scharf R, Trappe R, Holstein K, Huth-Kuhne A, et al.
Blood
. 2014 Dec;
125(7):1091-7.
PMID: 25525118
Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII). Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of patients over a period of...
9.
Spies-Weisshart B, Schilling K, Bohmer F, Hochhaus A, Sayer H, Scholl S
J Cancer Res Clin Oncol
. 2013 Jun;
139(8):1397-404.
PMID: 23728535
Purpose: The existence of platelet-derived growth factor (PDGF) receptor autoantibodies in systemic sclerosis is conflicting, and such antibodies were also detected in patients with chronic graft-versus-host disease (GvHD) after allogeneic...
10.
Rommeley M, Spies-Weisshart B, Schilling K, Hochhaus A, Sayer H, Scholl S
J Cancer Res Clin Oncol
. 2011 Jun;
137(9):1293-300.
PMID: 21713449
Purpose: The aim of the study was to investigate the recovery of the innate immune system within the first 100 days after allogeneic peripheral blood stem cell transplantation (PBSCT) and...